Pricing
Login
Home
Charts
Search
Watchlist
Products

Panacea Biotec Ltd

PANACEABIO
₹335.95-4.79%20 Nov 2026
Reports
Pharma Others

Panacea Biotec Ltd

PANACEABIO
₹335.95
-4.79%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹2,058Cr
Close
Close Price
₹335.95
Industry
Industry
Pharma Others
PE
Price To Earnings
111.61
PS
Price To Sales
2.85
Revenue
Revenue
₹721Cr
Rev Gr TTM
Revenue Growth TTM
19.43%
PAT Gr TTM
PAT Growth TTM
323.68%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
151136116147163133167141165167200190
Growth YoY
Revenue Growth YoY%
30.65.8-10.43.08.6-2.944.0-4.21.025.819.734.4
Expenses
ExpensesCr
151143130140156159168159153164194174
Operating Profit
Operating ProfitCr
0-6-1478-27-1-18123616
OPM
OPM%
-0.1-4.4-12.14.84.9-20.3-0.7-12.67.11.52.88.2
Other Income
Other IncomeCr
814776361795579
Interest Expense
Interest ExpenseCr
111111122111
Depreciation
DepreciationCr
999998888887
PBT
PBTCr
-2-2-175407-196-1417
Tax
TaxCr
10-10023-53015
PAT
PATCr
-2-2-1654-24-144-1212
Growth YoY
PAT Growth YoY%
-111.484.3-244.6156.8301.80.0124.9-397.4-12.449.8-44.4185.0
NPM
NPM%
-1.5-1.5-13.73.22.7-1.52.4-9.92.4-0.61.16.3
EPS
EPS₹
-0.4-0.2-2.60.80.7-0.30.7-2.30.70.10.41.9
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
151136116147163133167141165167200190
Growth YoY
Revenue Growth YoY%
30.65.8-10.43.08.6-2.944.0-4.21.025.819.734.4
Expenses
ExpensesCr
151143130140156159168159153164194174
Operating Profit
Operating ProfitCr
0-6-1478-27-1-18123616
OPM
OPM%
-0.1-4.4-12.14.84.9-20.3-0.7-12.67.11.52.88.2
Other Income
Other IncomeCr
814776361795579
Interest Expense
Interest ExpenseCr
111111122111
Depreciation
DepreciationCr
999998888887
PBT
PBTCr
-2-2-175407-196-1417
Tax
TaxCr
10-10023-53015
PAT
PATCr
-2-2-1654-24-144-1212
Growth YoY
PAT Growth YoY%
-111.484.3-244.6156.8301.80.0124.9-397.4-12.449.8-44.4185.0
NPM
NPM%
-1.5-1.5-13.73.22.7-1.52.4-9.92.4-0.61.16.3
EPS
EPS₹
-0.4-0.2-2.60.80.7-0.30.7-2.30.70.10.41.9

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
653544593457544625661460559559640721
Growth
Revenue Growth%
-5.0-16.79.0-23.019.114.85.8-30.421.60.014.419.4
Expenses
ExpensesCr
541482508588513548674558579585644686
Operating Profit
Operating ProfitCr
1126285-1313177-13-98-20-26-535
OPM
OPM%
17.111.514.3-28.75.812.3-2.0-21.3-3.6-4.6-0.74.9
Other Income
Other IncomeCr
7055833915101,68715462573627
Interest Expense
Interest ExpenseCr
12710110110517418518144465
Depreciation
DepreciationCr
736859544346443937353332
PBT
PBTCr
-19-52-6649-171-1441,449131-8-726
Tax
TaxCr
2-11108172371473109
PAT
PATCr
-21-41-7641-188-1461,078-34-2-9-717
Growth
PAT Growth%
79.7-96.2-85.8153.8-559.222.2837.6-103.195.5-479.317.9323.7
NPM
NPM%
-3.2-7.5-12.89.0-34.5-23.4163.1-7.3-0.3-1.6-1.12.4
EPS
EPS₹
-2.7-6.1-11.45.6-29.1-24.1176.0-5.4-0.2-1.4-0.93.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
653544593457544625661460559559640721
Growth
Revenue Growth%
-5.0-16.79.0-23.019.114.85.8-30.421.60.014.419.4
Expenses
ExpensesCr
541482508588513548674558579585644686
Operating Profit
Operating ProfitCr
1126285-1313177-13-98-20-26-535
OPM
OPM%
17.111.514.3-28.75.812.3-2.0-21.3-3.6-4.6-0.74.9
Other Income
Other IncomeCr
7055833915101,68715462573627
Interest Expense
Interest ExpenseCr
12710110110517418518144465
Depreciation
DepreciationCr
736859544346443937353332
PBT
PBTCr
-19-52-6649-171-1441,449131-8-726
Tax
TaxCr
2-11108172371473109
PAT
PATCr
-21-41-7641-188-1461,078-34-2-9-717
Growth
PAT Growth%
79.7-96.2-85.8153.8-559.222.2837.6-103.195.5-479.317.9323.7
NPM
NPM%
-3.2-7.5-12.89.0-34.5-23.4163.1-7.3-0.3-1.6-1.12.4
EPS
EPS₹
-2.7-6.1-11.45.6-29.1-24.1176.0-5.4-0.2-1.4-0.93.0
Sales CAGR
1 Year14%
3 Years12%
5 Years0%
TTM19%
Avg. ROCE
1 Year0%
3 Years0%
5 Years37%
TTM4%

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
666666666666
Reserves
ReservesCr
426340293335139-256849816814807807844
Current Liabilities
Current LiabilitiesCr
475588691938455449776330309367349391
Non Current Liabilities
Non Current LiabilitiesCr
9308466119073996010910194928590
Total Liabilities
Total LiabilitiesCr
1,8541,8001,6081,3761,3901,1781,7591,2711,2411,2901,2621,325
Current Assets
Current AssetsCr
549533560508683511951562485576513577
Non Current Assets
Non Current AssetsCr
1,3061,2671,047868707667808709755713749748
Total Assets
Total AssetsCr
1,8541,8001,6081,3761,3901,1781,7591,2711,2411,2901,2621,325
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
666666666666
Reserves
ReservesCr
426340293335139-256849816814807807844
Current Liabilities
Current LiabilitiesCr
475588691938455449776330309367349391
Non Current Liabilities
Non Current LiabilitiesCr
9308466119073996010910194928590
Total Liabilities
Total LiabilitiesCr
1,8541,8001,6081,3761,3901,1781,7591,2711,2411,2901,2621,325
Current Assets
Current AssetsCr
549533560508683511951562485576513577
Non Current Assets
Non Current AssetsCr
1,3061,2671,047868707667808709755713749748
Total Assets
Total AssetsCr
1,8541,8001,6081,3761,3901,1781,7591,2711,2411,2901,2621,325

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
91131118105-30107-108-4220-2717
Investing Cash Flow
Investing Cash FlowCr
16-2655-5-35-481,2834301065-41
Financing Cash Flow
Financing Cash FlowCr
-117-107-164-10191-47-1,176-18-3-3-1
Net Cash Flow
Net Cash FlowCr
-10-29-22612-2-10735-25
Free Cash Flow
Free Cash FlowCr
85107103100-2189-119-424-71-77-37
CFO To PAT
CFO To PAT%
-435.0-319.5-155.3256.216.2-73.0-10.11,251.96.6313.9-233.1
CFO To EBITDA
CFO To EBITDA%
81.2209.3139.6-79.9-97.2139.3821.4431.30.5105.6-358.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
91131118105-30107-108-4220-2717
Investing Cash Flow
Investing Cash FlowCr
16-2655-5-35-481,2834301065-41
Financing Cash Flow
Financing Cash FlowCr
-117-107-164-10191-47-1,176-18-3-3-1
Net Cash Flow
Net Cash FlowCr
-10-29-22612-2-10735-25
Free Cash Flow
Free Cash FlowCr
85107103100-2189-119-424-71-77-37
CFO To PAT
CFO To PAT%
-435.0-319.5-155.3256.216.2-73.0-10.11,251.96.6313.9-233.1
CFO To EBITDA
CFO To EBITDA%
81.2209.3139.6-79.9-97.2139.3821.4431.30.5105.6-358.2

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5689841,6361,2146711,0879086647432,6991,8142,058
Price To Earnings
Price To Earnings
32.20.8111.6
Price To Sales
Price To Sales
0.91.82.82.71.21.71.41.41.34.82.82.9
Price To Book
Price To Book
-20.92.85.53.64.6-4.31.10.80.93.32.22.4
EV To EBITDA
EV To EBITDA
14.430.027.8-9.938.223.1-27.2-4.7-31.1-100.9-380.556.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
57.758.254.643.156.951.242.724.137.843.541.341.3
OPM
OPM%
17.111.514.3-28.75.812.3-2.0-21.3-3.6-4.6-0.74.9
NPM
NPM%
-3.2-7.5-12.89.0-34.5-23.4163.1-7.3-0.3-1.6-1.12.4
ROCE
ROCE%
7.33.93.333.60.47.2183.32.00.6-0.5-0.23.5
ROE
ROE%
-4.8-11.8-25.412.0-129.658.4126.1-4.1-0.2-1.1-0.92.0
ROA
ROA%
-1.1-2.3-4.73.0-13.5-12.461.3-2.6-0.1-0.7-0.61.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5689841,6361,2146711,0879086647432,6991,8142,058
Price To Earnings
Price To Earnings
32.20.8111.6
Price To Sales
Price To Sales
0.91.82.82.71.21.71.41.41.34.82.82.9
Price To Book
Price To Book
-20.92.85.53.64.6-4.31.10.80.93.32.22.4
EV To EBITDA
EV To EBITDA
14.430.027.8-9.938.223.1-27.2-4.7-31.1-100.9-380.556.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
57.758.254.643.156.951.242.724.137.843.541.341.3
OPM
OPM%
17.111.514.3-28.75.812.3-2.0-21.3-3.6-4.6-0.74.9
NPM
NPM%
-3.2-7.5-12.89.0-34.5-23.4163.1-7.3-0.3-1.6-1.12.4
ROCE
ROCE%
7.33.93.333.60.47.2183.32.00.6-0.5-0.23.5
ROE
ROE%
-4.8-11.8-25.412.0-129.658.4126.1-4.1-0.2-1.1-0.92.0
ROA
ROA%
-1.1-2.3-4.73.0-13.5-12.461.3-2.6-0.1-0.7-0.61.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr3,7243,3022,0592,0581,569963394
Close PriceClose₹84.16468.9521.90335.951,110.15817.60893.20
IndustryIndustryPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma Others
Price To EarningsPE82.519.7421.68111.615.6719.5711.99
Price To SalesPS32.911.393.972.851.710.902.30
RevenueRevenueCr1132,3695187219181,068171
Revenue Growth TTMRev Gr TTM%222.2%6.4%0.6%19.4%11.3%42.7%7.8%
PAT Growth TTMPAT Gr TTM%270.5%283.1%51.6%323.7%317.3%16.8%-0.4%
Market CapitalizationMkt CapCr3,7243,3022,0592,0581,569963394
Close PriceClose₹84.16468.9521.90335.951,110.15817.60893.20
IndustryIndustryPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma Others
Price To EarningsPE82.519.7421.68111.615.6719.5711.99
Price To SalesPS32.911.393.972.851.710.902.30
RevenueRevenueCr1132,3695187219181,068171
Revenue Growth TTMRev Gr TTM%222.2%6.4%0.6%19.4%11.3%42.7%7.8%
PAT Growth TTMPAT Gr TTM%270.5%283.1%51.6%323.7%317.3%16.8%-0.4%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
ResultPPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
ResultPPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Load More
Interviews